B. Kaufmann

889 total citations
29 papers, 650 citations indexed

About

B. Kaufmann is a scholar working on Pharmacology, Analytical Chemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, B. Kaufmann has authored 29 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 7 papers in Analytical Chemistry and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in B. Kaufmann's work include Analytical Methods in Pharmaceuticals (7 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Analytical Chemistry and Chromatography (4 papers). B. Kaufmann is often cited by papers focused on Analytical Methods in Pharmaceuticals (7 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Analytical Chemistry and Chromatography (4 papers). B. Kaufmann collaborates with scholars based in Germany, United States and Switzerland. B. Kaufmann's co-authors include G Betzien, G. Neugebauer, U. Abshagen, W. Akpan, W. Schaumann, R. Endele, Peter Neubert, K. Reiff, E von Möllendorff and Ulrich Martin and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Thrombosis and Haemostasis and Clinical Pharmacokinetics.

In The Last Decade

B. Kaufmann

29 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Kaufmann Germany 14 247 107 95 86 86 29 650
A. Pottage United Kingdom 15 271 1.1× 67 0.6× 92 1.0× 82 1.0× 64 0.7× 26 552
H. Bechtold Germany 11 427 1.7× 109 1.0× 49 0.5× 69 0.8× 76 0.9× 27 768
Bernard E. Ilson United States 17 360 1.5× 72 0.7× 54 0.6× 112 1.3× 96 1.1× 33 825
E von Möllendorff United States 9 168 0.7× 43 0.4× 72 0.8× 61 0.7× 59 0.7× 12 430
DA Willard United States 13 140 0.6× 118 1.1× 74 0.8× 160 1.9× 72 0.8× 18 592
P Zech France 14 120 0.5× 75 0.7× 46 0.5× 89 1.0× 127 1.5× 56 749
Mitsutaka Kanamaru Japan 15 159 0.6× 187 1.7× 34 0.4× 53 0.6× 140 1.6× 44 698
Pertti J. Pentikäinen Finland 18 466 1.9× 74 0.7× 41 0.4× 173 2.0× 157 1.8× 32 937
Elizabeth Hand United States 13 330 1.3× 65 0.6× 58 0.6× 140 1.6× 107 1.2× 15 663
Lyle A. Siddoway United States 15 559 2.3× 86 0.8× 132 1.4× 97 1.1× 221 2.6× 25 1.1k

Countries citing papers authored by B. Kaufmann

Since Specialization
Citations

This map shows the geographic impact of B. Kaufmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Kaufmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Kaufmann more than expected).

Fields of papers citing papers by B. Kaufmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Kaufmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Kaufmann. The network helps show where B. Kaufmann may publish in the future.

Co-authorship network of co-authors of B. Kaufmann

This figure shows the co-authorship network connecting the top 25 collaborators of B. Kaufmann. A scholar is included among the top collaborators of B. Kaufmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Kaufmann. B. Kaufmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martin, Ulrich, et al.. (1999). Current Clinical Use of Reteplase for Thrombolysis. Clinical Pharmacokinetics. 36(4). 265–276. 21 indexed citations
2.
Kaufmann, B., et al.. (1997). Phase I/II trial with fozivudine tidoxil (BM 21.1290): a 7 day randomized, placebo-controlled dose-escalating trial.. PubMed. 2(4). 257–64. 6 indexed citations
3.
Kaufmann, B., et al.. (1996). Kinetics of Subcutaneous versus Intravenous Epoetin-Beta in Dogs, Rats and Mice. Pharmacology. 52(5). 329–338. 30 indexed citations
4.
Kaufmann, B. & W Wegmann. (1992). [Exogenous ochronosis after L-dopa treatment].. PubMed. 13(3). 164–6. 6 indexed citations
5.
Martin, Ulrich, et al.. (1991). Dose-ranging study of the novel recombinant plasminogen activator BM 06.022 in healthy volunteers. Clinical Pharmacology & Therapeutics. 50(4). 429–436. 22 indexed citations
6.
Neugebauer, G., W. Akpan, B. Kaufmann, & K. Reiff. (1990). Stereoselective disposition of carvedilol in man after intravenous and oral administration of the racemic compound. European Journal of Clinical Pharmacology. 38(S2). S108–S111. 98 indexed citations
7.
Martin, Ubaldo J., B. Kaufmann, Jens Köhler, G. Sponer, & K. Strein. (1990). Pharmacokinetics of t-PA produced in E. coli, in conscious dogs. Fibrinolysis and Proteolysis. 4. 90–90. 2 indexed citations
8.
Staiger, C, et al.. (1989). Pharmacokinetics of the thromboxane A2 receptor antagonist sulotroban (BM 13.177) in renal failure.. British Journal of Clinical Pharmacology. 28(3). 281–288. 1 indexed citations
9.
Kaufmann, B.. (1986). KINPAK--a program for standardized pharmacokinetic analysis.. PubMed. 8(10). 615–24. 1 indexed citations
10.
Schaumann, W., et al.. (1986). Kinetics of the fab fragments of digoxin antibodies and of bound digoxin in patients with severe digoxin intoxication. European Journal of Clinical Pharmacology. 30(5). 527–533. 82 indexed citations
11.
Patscheke, H., G. Neugebauer, B. Kaufmann, et al.. (1986). Single dose pharmacokinetics and effects on platelet function of the thromboxane receptor blocker BM 13.177. European Journal of Clinical Pharmacology. 29(5). 573–579. 9 indexed citations
12.
Patscheke, H., C Staiger, G. Neugebauer, et al.. (1986). The pharmacokinetic and pharmacodynamic profiles of the thromboxane A-2 receptor blocker BM 13.177. Clinical Pharmacology & Therapeutics. 39(2). 145–150. 13 indexed citations
13.
Abshagen, U., G Betzien, R. Endele, B. Kaufmann, & G. Neugebauer. (1985). Pharmacokinetics and metabolism of isosorbide-dinitrate after intravenous and oral administration. European Journal of Clinical Pharmacology. 27(6). 637–644. 25 indexed citations
14.
Neugebauer, G., et al.. (1985). Absolute bioavailability and bioequivalence of glibenclamide (Semi-Euglucon N).. PubMed. 23(9). 453–60. 36 indexed citations
15.
Betzien, G, B. Kaufmann, B. Schneider, & Ritschel Wa. (1985). Simulation studies of errors of parameter estimates in pharmacokinetics.. PubMed. 35(1). 7–14. 4 indexed citations
16.
Ritschel, W. A., et al.. (1985). Evaluation of bioavailability by different methods.. PubMed. 7(8). 439–49. 2 indexed citations
17.
Betzien, G, B. Kaufmann, & B. Schneider. (1982). Estimation of absorption ratios and their variation for orally administered drugs. European Journal of Clinical Pharmacology. 22(3). 265–272. 1 indexed citations
18.
Kaufmann, B., et al.. (1981). Pharmacokinetics of Metildigoxin and Digoxin in Geriatric Patients with Normal and Elevated Serum Creatinine Levels. Clinical Pharmacokinetics. 6(6). 463–468. 12 indexed citations
19.
Krück, F., et al.. (1978). Clinical and pharmacological investigations of the new saluretic azosemid. European Journal of Clinical Pharmacology. 14(3). 153–161. 44 indexed citations
20.
Larbig, D., F. Scheler, Hannelore Schmidt, G Betzien, & B. Kaufmann. (1971). Untersuchungen zur enteralen Resorption von?-Methyldigoxin. Journal of Molecular Medicine. 49(10). 604–607. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Pottage Breakdown of academic impact, for papers by H. Bechtold Breakdown of academic impact, for papers by Bernard E. Ilson Breakdown of academic impact, for papers by E von Möllendorff Breakdown of academic impact, for papers by DA Willard Breakdown of academic impact, for papers by P Zech Breakdown of academic impact, for papers by Mitsutaka Kanamaru Breakdown of academic impact, for papers by Pertti J. Pentikäinen Breakdown of academic impact, for papers by Elizabeth Hand Breakdown of academic impact, for papers by Lyle A. Siddoway
Rankless by CCL
2026